Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, et al. Protein Kinase Cδ Deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 2013;65(8):2161–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, et al. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ. Blood. 2013;121(16):3112–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, et al. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood. 2013;121(16):3117–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huppi K, Siwarski D, Goodnight J, Mischak H. Assignment of the protein kinase C delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. Genomics. 1994;19(1):161–2.

Article  CAS  PubMed  Google Scholar 

Duquesnes N, Lezoualc’h F, Crozatier B. PKC-delta and PKC-epsilon: foes of the same family or strangers? J Mol Cell Cardiol. 2011;51(5):665–73.

Article  CAS  PubMed  Google Scholar 

Salzer E, Santos-Valente E, Keller B, Warnatz K, Boztug K. Protein kinase C δ: a gatekeeper of immune homeostasis. J Clin Immunol. 2016;36(7):631–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neehus AL, Moriya K, Nieto-Patlán A, Le Voyer T, Lévy R, Özen A, et al. Impaired respiratory burst contributes to infections in PKCδ-deficient patients. J Exp Med [Internet]. J Exp Med 2021;218(9):e20210501. https://doi.org/10.1084/jem.20210501

Limnander A, Zikherman J, Lau T, Leitges M, Weiss A, Roose JP. Protein kinase Cδ promotes transitional B cell-negative selection and limits proximal B cell receptor signaling to enforce tolerance. Mol Cell Biol. 2014;34(8):1474–85.

Article  PubMed  PubMed Central  Google Scholar 

Guo B, Rothstein TL. A novel Lyn-protein kinase Cδ/ε-protein kinase D axis is activated in B cells by signalosome-independent alternate pathway BCR signaling. Eur J Immunol. 2013;43(6):1643–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fukao S, Haniuda K, Tamaki H, Kitamura D. Protein kinase Cδ is essential for the IgG response against T-cell-independent type 2 antigens and commensal bacteria. eLife. 2021;10:e72116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorelik G, Sawalha AH, Patel D, Johnson K, Richardson B. T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice. Clin Immunol Orlando Fla. 2015;158(2):193–203.

Article  CAS  Google Scholar 

Gruber T, Barsig J, Pfeifhofer C, Ghaffari-Tabrizi N, Tinhofer I, Leitges M, et al. PKCdelta is involved in signal attenuation in CD3+ T cells. Immunol Lett. 2005;96(2):291–3.

Article  CAS  PubMed  Google Scholar 

Schwegmann A, Guler R, Cutler AJ, Arendse B, Horsnell WGC, Flemming A, et al. Protein kinase C δ is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes. Proc Natl Acad Sci. 2007;104(41):16251–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Contreras X, Mzoughi O, Gaston F, Peterlin MB, Bahraoui E. Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages. Retrovirology. 2012;9(1):37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Cullere X, Nishi H, Saggu G, Durand E, Mansour MK, et al. PKC-δ activation in neutrophils promotes fungal clearance. J Leukoc Biol. 2016;100(3):581–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheats MK, Sung EJ, Adler KB, Jones SL. In vitro neutrophil migration requires protein kinase c-delta (δ-PKC) mediated MARCKS (myristoylated alanine rich C-kinase substrate) phosphorylation. Inflammation. 2015;38(3):1126–41.

Article  CAS  PubMed  Google Scholar 

Mecklenbräuker I, Saijo K, Zheng NY, Leitges M, Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature. 2002;416(6883):860–5.

Article  PubMed  Google Scholar 

Moreews M, Mathieu AL, Pouxvielh K, Reuschlé Q, Drouillard A, Dessay P, et al. mTOR activation underlies enhanced B cell proliferation and autoimmunity in PrkcdG510S/G510S mice. J Immunol. 2023;210(9):1209–21.

Article  CAS  PubMed  Google Scholar 

Yanase N, Hayashida M, Kanetaka-Naka Y, Hoshika A, Mizuguchi J. PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH2-terminal kinase activation. BMC Cell Biol. 2012;21(13):7.

Article  Google Scholar 

Yoshida K, Miki Y, Kufe D. Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage. J Biol Chem. 2002;277(50):48372–8.

Article  CAS  PubMed  Google Scholar 

Yang H, Hu Z, Zhang J, Lowire DB, Liu TF, Fan XY, et al. Disseminated BCG disease with defective immune metabolism caused by protein kinase C delta deficiency. J Allergy Clin Immunol Pract. 2022;S2213–2198(22):00865.

Google Scholar 

Neehus AL, Tuano K, Le Voyer T, Nandiwada SL, Murthy K, Puel A, et al. Chronic granulomatous disease-like presentation of a child with autosomal recessive PKCδ deficiency. J Clin Immunol. 2022;42(6):1244–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiykim A, Ogulur I, Baris S, Salzer E, Karakoc-Aydiner E, Ozen AO, et al. Potentially beneficiaSl effect of hydroxychloroquine in a patient with a novel mutation in protein kinase Cδ deficiency. J Clin Immunol. 2015;35(6):523–6.

Article  PubMed  Google Scholar 

Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, et al. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood. 2013;121(16):3117–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu H, Chen Z, Ma J, Wang J, Zhang R, Wu R, et al. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: a pedigree case report with homozygous variation PRKCD. Int J Immunopathol Pharmacol. 2021;35:20587384211025936.

Article  Google Scholar 

Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, et al. Early-onset juvenile SLE associated with a novel mutation in protein kinase C δ. Pediatrics. 2017;139(1):e20160781. https://doi.org/10.1542/peds.2016-0781

Lei L, Muhammad S, Al-Obaidi M, Sebire N, Cheng IL, Eleftheriou D, et al. Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ. Pediatr Rheumatol Online J. 2018;16(1):61.

Article  PubMed  PubMed Central  Google Scholar 

Sharifinejad N, Azizi G, Behniafard N, Zaki-Dizaji M, Jamee M, Yazdani R, et al. Protein kinase C-delta defect in autoimmune lymphoproliferative syndrome-like disease: first case from the National Iranian Registry and review of the literature. Immunol Invest. 2020;13:1–12.

Google Scholar 

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21.

Article  CAS  PubMed  Google Scholar 

Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet Lond Engl. 2013;382(9894):819–31.

Article  CAS  Google Scholar 

Roderick MR, Jefferson L, Renton W, Belot A, PRKCD Consortium. Compound heterozygous mutations in PRKCD associated with early-onset lupus and severe and invasive infections in siblings. J Clin Immunol. 2023;43(4):703-705. https://doi.org/10.1007/s10875-022-01416-0

Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B. 2007 Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol Baltim Md. 1950;179(8):5553–63.

Google Scholar 

Rieux-Laucat F, Magérus-Chatinet A, Neven B. The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol. 2018;38(5):558–68.

Article  CAS  PubMed  Google Scholar 

Chuang SS, Lee JK, Mathew PA. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Immunology. 2003;109(3):432–9.

Article  CAS  PubMed  PubMed Central  Google Scholar